Bone Therapeutics

Headquartered at the Biopôle of Gosselies (South of Brussels, Belgium), Bone Therapeutics is a leading international biotechnology company specialized in the treatment of osteo-articular diseases using cell therapy. With its proprietary cell technology platform, the Company is developing innovative cell products for the repair and regeneration of bone and joint tissues. The Company’s leading position in skeletal tissue reparation is supported by an outstanding knowledge of the bone physiology and pathophysiology, the pioneering works of its founders in stem cell transplantation in humans and a long-standing expertise in cell therapy clinical trials and regulatory affairs.
Type
Public
HQ
Charleroi, BE
Founded
2006
Size (employees)
101 (est)
Bone Therapeutics was founded in 2006 and is headquartered in Charleroi, BE

Bone Therapeutics Office Locations

Bone Therapeutics has an office in Charleroi
Charleroi, BE (HQ)
37 Rue Auguste Piccard

Bone Therapeutics Data and Metrics

Bone Therapeutics Financial Metrics

EUR

Market capitalization (22-Mar-2017)

52.3 b

Closing share price (22-Mar-2017)

7.6
Bone Therapeutics's current market capitalization is €52.3 b.

Bone Therapeutics Market Value History

Bone Therapeutics Online and Social Media Presence

Bone Therapeutics Company Life and Culture

You may also be interested in